Alex Kolicich focuses on IT and Bio-IT investments.
Prior to joining 8VC, Alex was a Partner at Formation 8. Alex also worked with Peter Thiel as a Principal at Mithril Capital Management, a growth-stage venture fund, where he helped lead investments in AppDirect, C2FO and Helion Energy.
Preceding his venture career, Alex worked as engineer and early-product advisor at Clarium, Palantir, and Google. He was an early member of the Clarium Capital quantitative engineering team (with Joe Lonsdale) and close advisor/collaborator with the early Palantir team; advising on product design and contributing to the product. At Google Research, Alex worked on Google Street-Views before and during launch. Preceding Street-Views, also at Google, he worked on the development and launch of the Google Checkout product.
What’s a Rich Text element?
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
Static and dynamic content editing
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
How to customize formatting for each rich text
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
Amjad Masad (Replit) Fireside Chat
We were delighted to engage in a dynamic conversation with Amjad Masad, founder and CEO of Replit during our August Chat8VC gathering. As a reminder, Chat8VC is a monthly series hosted at our SF office where we bring together founders and early-phase operators excited about the foundation model ecosystem. We focus on having highly technical, implementation-oriented conversations and give founders and builders the opportunity to showcase what they’re working on through lightning demos and fireside chats. This can be a fun side project, related to a company they’re starting, or a high-leverage use case within a company operating at scale.
Amjad Masad (Replit) Fireside Chat
We were delighted to engage in a dynamic conversation with Amjad Masad, founder and CEO of Replit during our August Chat8VC gathering. As a reminder, Chat8VC is a monthly series hosted at our SF office where we bring together founders and early-phase operators excited about the foundation model ecosystem. We focus on having highly technical, implementation-oriented conversations and give founders and builders the opportunity to showcase what they’re working on through lightning demos and fireside chats. This can be a fun side project, related to a company they’re starting, or a high-leverage use case within a company operating at scale.
Announcing Twingate’s Series B Funding Round
Earlier this week, Twingate announced their $42 million Series B, led by BOND. It has been an absolute pleasure working with the Twingate team since day one when we co-led their seed and Series A rounds. It has been wonderful watching the team bring the zero trust vision to network security and we wanted to share some of the thinking around why we believe the opportunity and Twingate’s approach are truly special.
Announcing Twingate’s Series B Funding Round
Earlier this week, Twingate announced their $42 million Series B, led by BOND. It has been an absolute pleasure working with the Twingate team since day one when we co-led their seed and Series A rounds. It has been wonderful watching the team bring the zero trust vision to network security and we wanted to share some of the thinking around why we believe the opportunity and Twingate’s approach are truly special.
Less Risk, More Practice
Earlier this month, Fieldguide announced their $17 million Series A, led by 8VC. Fieldguide CEO Jin Chang’s excellent blog post conveys both the tremendous functional appetite for their platform, and their larger mission to empower risk practices to increase trust in commerce and capital markets.
Less Risk, More Practice
Earlier this month, Fieldguide announced their $17 million Series A, led by 8VC. Fieldguide CEO Jin Chang’s excellent blog post conveys both the tremendous functional appetite for their platform, and their larger mission to empower risk practices to increase trust in commerce and capital markets.
Announcing Subskribe Series A
Over the past few years, we’ve watched as subscriptions have become both an increasingly prevalent business model for leading software businesses, as well as a modernizing force for legacy companies.
Announcing Subskribe Series A
Over the past few years, we’ve watched as subscriptions have become both an increasingly prevalent business model for leading software businesses, as well as a modernizing force for legacy companies.
Working at the Speed of Thought: Investing in Wispr AI
The essence of being a good venture capitalist is making moonshot bets. Sometimes that means backing entrepreneurs who build new software workflows for stagnant, legacy industries; other times, it means backing entrepreneurs who push the boundaries of what we can do as humans and as a society by building platforms to capitalize on breakthroughs in fundamental research.
Working at the Speed of Thought: Investing in Wispr AI
The essence of being a good venture capitalist is making moonshot bets. Sometimes that means backing entrepreneurs who build new software workflows for stagnant, legacy industries; other times, it means backing entrepreneurs who push the boundaries of what we can do as humans and as a society by building platforms to capitalize on breakthroughs in fundamental research.
Announcing Our Investment in Orca Bio
Every year in America, roughly 23,000 people undergo a Bone Marrow Transplant (BMT). These procedures are typically last-line interventions to save cancer patients. When successful, the therapy is often curative.
Announcing Our Investment in Orca Bio
Every year in America, roughly 23,000 people undergo a Bone Marrow Transplant (BMT). These procedures are typically last-line interventions to save cancer patients. When successful, the therapy is often curative.
